These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22591278)

  • 21. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
    Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment.
    Derave W; Van Den Bosch L; Lemmens G; Eijnde BO; Robberecht W; Hespel P
    Neurobiol Dis; 2003 Aug; 13(3):264-72. PubMed ID: 12901841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different human copper-zinc superoxide dismutase mutants, SOD1G93A and SOD1H46R, exert distinct harmful effects on gross phenotype in mice.
    Pan L; Yoshii Y; Otomo A; Ogawa H; Iwasaki Y; Shang HF; Hadano S
    PLoS One; 2012; 7(3):e33409. PubMed ID: 22438926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
    Apolloni S; Fabbrizio P; Amadio S; Volonté C
    J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of diet on adenosine monophosphate-activated protein kinase activity and disease progression in an amyotrophic lateral sclerosis model.
    Zhao Z; Sui Y; Gao W; Cai B; Fan D
    J Int Med Res; 2015 Feb; 43(1):67-79. PubMed ID: 25534414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A major QTL on mouse chromosome 17 resulting in lifespan variability in SOD1-G93A transgenic mouse models of amyotrophic lateral sclerosis.
    Sher RB; Heiman-Patterson TD; Blankenhorn EA; Jiang J; Alexander G; Deitch JS; Cox GA
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Dec; 15(7-8):588-600. PubMed ID: 25008789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS.
    Heiman-Patterson TD; Deitch JS; Blankenhorn EP; Erwin KL; Perreault MJ; Alexander BK; Byers N; Toman I; Alexander GM
    J Neurol Sci; 2005 Sep; 236(1-2):1-7. PubMed ID: 16024047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
    Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
    Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Riluzole does not improve lifespan or motor function in three ALS mouse models.
    Hogg MC; Halang L; Woods I; Coughlan KS; Prehn JHM
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Aug; 19(5-6):438-445. PubMed ID: 29221425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
    Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
    Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice.
    Turner BJ; Ackerley S; Davies KE; Talbot K
    Hum Mol Genet; 2010 Mar; 19(5):815-24. PubMed ID: 20008901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Galectin-1 deficiency improves axonal swelling of motor neurones in SOD1(G93A) transgenic mice.
    Kobayakawa Y; Sakumi K; Kajitani K; Kadoya T; Horie H; Kira J; Nakabeppu Y
    Neuropathol Appl Neurobiol; 2015 Feb; 41(2):227-44. PubMed ID: 24707896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Ovariectomy in an hSOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (ALS).
    Yan L; Liu Y; Sun C; Zheng Q; Hao P; Zhai J; Liu Y
    Med Sci Monit; 2018 Feb; 24():678-686. PubMed ID: 29394243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.
    Sheean RK; Weston RH; Perera ND; D'Amico A; Nutt SL; Turner BJ
    J Neuroinflammation; 2015 Feb; 12():40. PubMed ID: 25889790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Nagahara Y; Shimazawa M; Tanaka H; Ono Y; Noda Y; Ohuchi K; Tsuruma K; Katsuno M; Sobue G; Hara H
    J Neurosci Res; 2015 Oct; 93(10):1552-66. PubMed ID: 26140698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune response in peripheral axons delays disease progression in SOD1
    Nardo G; Trolese MC; de Vito G; Cecchi R; Riva N; Dina G; Heath PR; Quattrini A; Shaw PJ; Piazza V; Bendotti C
    J Neuroinflammation; 2016 Oct; 13(1):261. PubMed ID: 27717377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective effects of diallyl trisulfide in SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis.
    Guo Y; Zhang K; Wang Q; Li Z; Yin Y; Xu Q; Duan W; Li C
    Brain Res; 2011 Feb; 1374():110-5. PubMed ID: 21147075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of the neurochemical profiles in the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
    Lei H; Dirren E; Poitry-Yamate C; Schneider BL; Gruetter R; Aebischer P
    J Cereb Blood Flow Metab; 2019 Jul; 39(7):1283-1298. PubMed ID: 29400109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.